drugset / Trial / NCT00308100
Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation
RandomizedParallel-groupOpen-labelTreatment
Summary
There are no standardized plasma volume replacement protocols during liver transplantation surgery. The current study is designed to compare efficacy, safety, and costs of perioperative volume replacement with Voluven (Hydroxyethyl starch 130/0.4) and albumin in patients undergoing liver transplantation.
Timeline
- Start
- 2005-10
- Primary completion
- 2008-07
- Completion
- 2008-07
Outcome
Outcome not reported
Stopped (Enrollment): “Study is prematurely ended due to poor patient recruitment rate.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Albumin | Protein / enzyme biologic | — | — |
| Subject | Volulyte | Other / unclassified | 33 unknown | — |
Indications
No indication recorded.